Neurocrine Biosciences Inc NBIX 164.63 4.87 3.05%
Expected move
November 06, 2026 close · $164.77| Horizon | Expected move | Typical range | 2 in 3 closes | 9 in 10 closes |
|---|---|---|---|---|
| Next session | ±1.6% ±$2.65 | $162.12 – $167.42 | $161.59 – $167.95 | $159.09 – $170.45 |
| 2 sessions | ±2.2% ±$3.69 | $161.08 – $168.46 | $160.30 – $169.24 | $156.83 – $172.71 |
| 3 sessions | ±2.8% ±$4.65 | $160.12 – $169.42 | $159.23 – $170.31 | $154.88 – $174.66 |
| 1 week | ±3.6% ±$5.90 | $158.87 – $170.67 | $157.55 – $171.99 | $152.20 – $177.34 |
| 2 weeks | ±5.0% ±$8.27 | $156.50 – $173.04 | $154.54 – $175.00 | $147.11 – $182.43 |
| 3 weeks | ±6.0% ±$9.89 | $154.88 – $174.66 | $152.48 – $177.06 | $143.88 – $185.66 |
| 1 month | ±7.0% ±$11.52 | $153.25 – $176.29 | $150.40 – $179.14 | $140.35 – $189.19 |
Earnings: priced against what happened
Average implied move
±8.65%
Average actual move
9.64%
Beyond the implied move
1 / 2
| Reaction session | Implied | Actual | Used | ATM IV before → after |
|---|---|---|---|---|
| May 06, 2026 | ±8.92% | +8.86% | 0.99× | — |
| February 12, 2026 | ±8.39% | -10.43% | 1.24× | — |